Immunoregulation of Theiler's virus-induced demyelinating disease by glatiramer acetate without suppression of antiviral immune responses.
Immunoregulation of Theiler's virus-induced demyelinating disease by glatiramer acetate without suppression of antiviral immune responses.
复制标题
DOI:
10.1007/s00705-018-3729-6
复制
发表时间:
2018-05
影响因子:
2.7
通讯作者:
Tsunoda I
中科院分区:
文献类型:
--
作者:
Omura S;Sato F;Martinez NE;Range T;Ekshyyan L;Minagar A;Alexander JS;Tsunoda I
While most disease-modifying drugs (DMDs) regulate multiple sclerosis (MS) by suppressing inflammation, they can potentially suppress antiviral immunity, causing progressive multifocal leukoencephalopathy (PML). The DMD glatiramer acetate (GA) has been used for MS patients who are at high risk of PML. We investigated whether GA is safe for use in viral infections by using a model of MS induced by infection with Theiler’s murine encephalomyelitis virus (TMEV). Treatment of TMEV-infected mice with GA neither enhanced viral loads nor suppressed antiviral immune responses, while it resulted in an increase in the Foxp3/Il17a ratio and IL-4/IL-10 production. This is the first study to suggest that GA could be safe for MS patients with a proven viral infection.
登录
查看更多内容
DOI:
10.1007/s00281-002-0105-z
发表时间:
2002
期刊:
Springer seminars in immunopathology
影响因子:
--
作者:
Tsunoda I;Fujinami RS
通讯作者:
Fujinami RS
影响因子:
5.4
作者:
Asakura, K;Murayama, H;Ohara, Y
通讯作者:
Ohara, Y
DOI:
10.1038/nrneurol.2015.14
发表时间:
2015-03
期刊:
Nature reviews. Neurology
影响因子:
--
作者:
Ransohoff RM;Hafler DA;Lucchinetti CF
通讯作者:
Lucchinetti CF
DOI:
10.1111/bpa.12119
发表时间:
2014-09
期刊:
Brain pathology (Zurich, Switzerland)
影响因子:
--
作者:
Martinez NE;Karlsson F;Sato F;Kawai E;Omura S;Minagar A;Grisham MB;Tsunoda I
通讯作者:
Tsunoda I
影响因子:
5.3
作者:
Aharoni, Rina;Sasson, Efrat;Arnon, Ruth
通讯作者:
Arnon, Ruth